The Administration Core includes Consortium Administration and Senior Leadership. Consortium Administration provides high quality, efficient and effective support to cancer center leaders, programs and members. Administration plays a major role in enabling the Consortium's scientific leaders to define the center's vision and strategic goals, implement initiatives, monitor progress in achieving objectives and secure needed resources to develop the requisite infrastructure to carry out the center's mission. Senior Leaders work together to establish a vision and implement strategies of high importance to the cancer center's development. In addition to the Center Director, Dr. Corey, senior leadership includes: two Deputy Directors, including one who oversees Clinical Research; three scientific Associate Directors (AD) for Basic Sciences, Population Sciences, and Childhood Cancers; four ADs for special areas that are high strategic priorities of the center (Solid Tumor Translational Research, Global Oncology, Minority Health and Health Disparities, Inter-Institutional Initiatives), and an AD for Administration. Together, Administration and Senior Leaders provide the necessary leadership and structure to ensure that the center is well positioned to achieve its overarching goals to improve diagnosis, treatment and prevention of cancer.
The Specific Aims of this core are to provide: 1. Efficient and cost-effective administrative coordination for the cancer center including support for CCSG grant administration, budget management, communication and coordination across the partners, and other administrative functions to support and optimize the Consortium's research productivity. 2. Efficient oversight and management of CCSG Shared Resources to assure provision of services of the highest quality. 3. Expert leadership for clinical, basic and population-based cancer research; and other areas that are high strategic priorities of the center. 4. Executive leadership and oversight of planning and execution of the cancer center vision; fostering interdisciplinary translational and inter-institutional research of the center; engaging members in the center; fostering team science and career development; and addressing the health needs of the catchment area through research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA015704-43
Application #
9406700
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-01-01
Budget End
2018-12-31
Support Year
43
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
078200995
City
Seattle
State
WA
Country
United States
Zip Code
98109
Georges, George E; Doney, Kris; Storb, Rainer (2018) Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment. Blood Adv 2:2020-2028
Duggan, Catherine; Tapsoba, Jean de Dieu; Stanczyk, Frank et al. (2018) Long-term weight loss maintenance, sex steroid hormones, and sex hormone-binding globulin. Menopause :
Yu, Ming; Maden, Sean K; Stachler, Matthew et al. (2018) Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis. Gut :
Lam, Hung-Ming; Corey, Eva (2018) Supraphysiological Testosterone Therapy as Treatment for Castration-Resistant Prostate Cancer. Front Oncol 8:167
Fowler, Kyle R; Hyppa, Randy W; Cromie, Gareth A et al. (2018) Physical basis for long-distance communication along meiotic chromosomes. Proc Natl Acad Sci U S A 115:E9333-E9342
Ogimi, Chikara; Xie, Hu; Leisenring, Wendy M et al. (2018) Initial High Viral Load Is Associated with Prolonged Shedding of Human Rhinovirus in Allogeneic Hematopoietic Cell Transplant Recipients. Biol Blood Marrow Transplant 24:2160-2163
Jeong, Kyoung Sook; Zhou, Jin; Griffin, Stephanie C et al. (2018) MicroRNA Changes in Firefighters. J Occup Environ Med 60:469-474
Appelbaum, Jacob; Wells, David; Hiatt, Joseph B et al. (2018) Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report. J Immunother Cancer 6:82
Blair, Kris M; Mears, Kevin S; Taylor, Jennifer A et al. (2018) The Helicobacter pylori cell shape promoting protein Csd5 interacts with the cell wall, MurF, and the bacterial cytoskeleton. Mol Microbiol 110:114-127
Talarico, Sarah; Korson, Andrew S; Leverich, Christina K et al. (2018) High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR. Helicobacter 23:e12472

Showing the most recent 10 out of 1267 publications